Six-month immune responses to mRNA-1273 vaccine in combination antiretroviral therapy treated late presenter people with HIV according to previous SARS-CoV-2 infection

Immune responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccines in people with HIV (PWH) with a history of late presentation (LP) and their durability have not been fully characterized. In this prospective, longitudinal study, we sought to assess T-cell and humoral res...

Full description

Bibliographic Details

Published in:	AIDS (London) Vol. 37; no. 10; p. 1503
Main Authors:	Augello, Matteo, Bono, Valeria, Rovito, Roberta, Tincati, Camilla, d'Arminio Monforte, Antonella, Marchetti, Giulia
Format:	Journal Article
Language:	English
Published:	England 01.08.2023
Subjects:	2019-nCoV Vaccine mRNA-1273 Angiotensin-Converting Enzyme 2 Antiretroviral Therapy, Highly Active COVID-19 - prevention & control Cytokines HIV Infections - drug therapy Humans Longitudinal Studies Prospective Studies SARS-CoV-2
ISSN:	1473-5571, 1473-5571
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!